Femme et Homme
- | Pays :
- United States
- Ukraine
- | Organes : -
- | Spécialités : -
Extrait
The study will be conducted at up to 80 centers worldwide and will be a double-blind randomized parallel group placebo controlled study among subjects with stable coronary artery disease (CAD). Subjects will be randomized to receive either placebo tablets or one of 4 orally active doses of A-002. The duration of study drug therapy will be 8 weeks.
Critère d'inclusion
- coronary artery disease (CAD)